The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Brovkina A.F.

Russian Medical Academy of Postdegree Education, Moscow, Russia

Iatsenko O.Iu.

Rossiĭskaia meditsinskaia akademiia poslediplomnogo obrazovaniia, Moskva

Rationale for distinguishing the lipogenic form of thyroid orbitopathy

Authors:

Brovkina A.F., Iatsenko O.Iu.

More about the authors

Journal: Russian Annals of Ophthalmology. 2013;129(2): 28‑32

Read: 1122 times


To cite this article:

Brovkina AF, Iatsenko OIu. Rationale for distinguishing the lipogenic form of thyroid orbitopathy. Russian Annals of Ophthalmology. 2013;129(2):28‑32. (In Russ.)

References:

  1. Brovkina A.F. Endokrinnaya oftal'mopatiya. M: GEOTAR-Media 2004; 176.
  2. Brovkina A.F., Yatsenko O.Yu., Aubakirova A.S. Kharakteristika myagkikh tkanei orbity u bol'nykh otechnym ekzoftal'mom v svete komp'yuternoi tomografii. Oftal'mologiya 2006; 3: 1: 26-30.
  3. Anderson R.L., Tweeten J.P., Patrinely J.R., Garland P.E., Thiese S.M. Dysthyroid optic neuropathy without extraocular muscle involvement. Ophth Surg 1989; 20: 568-574.
  4. Bahn R.S. Pathophysiology of Graves' ophthalmopathy: the cycle of disease. J Clin Endocrinol Metab 2003; 88: 5: 1939-1946.
  5. Bartalena L., Pinchera A., Marcocci C. Management of Graves' ophthalmopathy: reality and perspectives. Endocr Rev 2000; 21: 168-199.
  6. Bartalena L., Tanda M. Graves' ophthalmopathy. N Engl J Med 2009; 360: 994-1001.
  7. Bartley G.B., Fatourechi V., Kadrmas E.F., Jacobsen S.J., Ilstrup D.M., Garrity J.A., Gorman C.A. Clinical features of Graves' ophthalmopathy in an incidence cohort. Am J Ophthalmol 1996; 121: 284-290.
  8. Forbes G., Gorman C.A., Brennan M.D., Gehring D.G., Ilstrup D.M., Earnest F. Ophthalmopathy of Graves' disease: computerized volume measurements of the orbital fat and muscle. Am J Neuroradiol 1986; 651-656.
  9. Hiromatsu Y., Yang D., Bednarczuk T., Miyake I., Nonaka K., Inoue Y. Cytokine profiles in eye muscle tissue and orbital fat tissue from patients with thyroid-associated ophthalmopathy. J Clin Endocrinol Metab 2000; 85: 1194-1199.
  10. Ing E. Thyroid-associated orbitopathy. Updated: Jan 17, 2012.
  11. Kazim M., Trokel S.L., Acaroglu G., Elliott A. Reversal of dysthyroid optic neuropathy following orbital fat decompression. // Br J Ophthalmol 2000; 84: 6: 600-605.
  12. Kazim M., Goldberg R.A., Smith T.J. Insights into the pathogenesis of thyroid-associated orbitopathy. Arch Ophthalmol 2002; 120: 3: 380-386.
  13. Orgiazzi J. Pathogenesis. In: Graves' orbitopathy: a multidisciplinary approach. Wiersinga W.M., Kahaly G.J. eds. Basel: Karger 2007; 41-56.
  14. Prabhakar B.S., Bahn R.S., Smith T.J. Current perspective on the pathogenesis of Graves' disease and ophthalmopathy. Endocr Rev 2003; 24: 802-835.
  15. Rubin P.A.D., Watkins L.M., Rumelt S., Sutula F.C., Dallow R.L. Orbital computed tomographic characteristics of globe subluxation in thyroid orbitopathy. Ophthalmology 1998; 105: 11: 2061-2064.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.